[Form 4] Vita Coco Company, Inc. Insider Trading Activity

Rhea-AI Filing Summary

Jane Prior, Chief Marketing Officer of Vita Coco Company, Inc. (COCO), reported transactions dated 09/12/2025. She acquired 10,000 shares of common stock by exercising non-qualified stock options at an exercise price of $10.178 per share and simultaneously sold 10,000 shares pursuant to a Rule 10b5-1 trading plan for a weighted average price of $40.002 per share (sales ranged $40.00–$40.03). After these transactions her beneficial ownership is reported as 123,666 shares. The filing lists outstanding non-qualified stock options covering additional shares (totaling ~155,739 underlying shares across multiple grants) with various vesting schedules and exercise prices, several of which are fully vested and exercisable.

Positive

• Acquisition via option exercise of 10,000 shares at an exercise price of $10.178, demonstrating alignment of compensation with equity ownership
• Transparent sale under a Rule 10b5-1 plan with weighted average sale price disclosed ( $40.002 ) and range provided
• Substantial remaining equity and option holdings after transactions (reported 123,666 shares beneficially owned and multiple option grants disclosed)

Negative

• Disposition of 10,000 shares reduced immediate beneficial ownership, reported sale at a weighted average of $40.002
• Significant number of outstanding options (multiple grants totaling ~155,739 underlying shares) could dilute existing shareholders if exercised and sold

Insights

Securities Analyst

TL;DR: Insider exercised options and sold an equal number of shares under a 10b5-1 plan, leaving substantial remaining equity and option holdings.

These transactions are routine compensation-related activity: Prior exercised 10,000 options at $10.178 and sold 10,000 shares under a pre-established Rule 10b5-1 plan at a weighted average of $40.002. The net reported beneficial ownership after the transactions is 123,666 shares. The Form also discloses multiple option grants with varying vesting schedules and exercise prices, several fully vested and exercisable, indicating continued potential for future exercises and sales. Impact to investors is limited and informational rather than material to company operations.

Corporate Governance Expert

TL;DR: Disclosure follows standard governance practices; use of a 10b5-1 plan indicates pre-planned sales to avoid timing concerns.

The filing properly identifies the reporting person as an officer and details the use of a Rule 10b5-1 plan for the sales, including a weighted average sale price and a commitment to provide granular sale information on request. Multiple option grants with explicit vesting schedules are disclosed, including several fully vested options. From a governance standpoint, the filing is complete and transparent about the nature of the transactions and remaining incentive compensation exposure.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

Prior Jane

(Last) (First) (Middle)

250 PARK AVE SOUTH

SEVENTH FLOOR

(Street)

NEW YORK NY 10003

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Vita Coco Company, Inc. [ COCO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Marketing Officer

3. Date of Earliest Transaction (Month/Day/Year)
09/12/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/12/2025		M		10,000	A	$10.178	133,666	D
Common Stock	09/12/2025		S(1)		10,000	D	$40.002(2)	123,666	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Non-Qualified Stock Option (right to buy)	$10.178	09/12/2025		M			10,000	(3)	02/10/2030	Common Stock	10,000	$0.0	43,750	D
Non-Qualified Stock Option (right to buy)	$10.178							(4)	12/16/2029	Common Stock	3,675		3,675	D
Non-Qualified Stock Option (right to buy)	$10.178							(5)	01/11/2031	Common Stock	27,300		27,300	D
Non-Qualified Stock Option (right to buy)	$15							(6)	10/21/2031	Common Stock	45,605		45,605	D
Non-Qualified Stock Option (right to buy)	$15.36							(7)	08/15/2032	Common Stock	42,980		42,980	D
Non-Qualified Stock Option (right to buy)	$16.91							(8)	03/10/2033	Common Stock	14,205		14,205	D
Non-Qualified Stock Option (right to buy)	$26.18							(9)	03/04/2034	Common Stock	8,746		8,746	D
Non-Qualified Stock Option (right to buy)	$33.36							(10)	03/04/2035	Common Stock	13,218		13,218	D

Explanation of Responses:

1. The sales of shares of common stock reported were effected pursuant to a Rule 10b5-1 trading plan.

2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.00 to $40.03, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

3. The stock option is fully vested and currently exercisable.

4. The stock option is fully vested and currently exercisable.

5. The stock option is fully vested and currently exercisable.

6. The stock option vests in four equal annual installments beginning on November 27, 2022.

7. The stock option vests in three equal annual installments beginning on August 15, 2025.

8. The stock option vests in four equal annual installments beginning on March 10, 2024.

9. The stock option vests in four equal annual installments beginning on March 4, 2025.

10. The Reporting Person was granted stock options that will vest in four annual equal installments on each anniversary of the grant date provided that the Reporting Person remains in continuous service on each vesting date.

	By: Alison Klein, Attorney-in-Fact For: Jane Prior	09/16/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transactions did Jane Prior (COCO) report on 09/12/2025?

The filing shows Prior exercised 10,000 options at $10.178 per share and sold 10,000 shares under a Rule 10b5-1 plan at a weighted average price of $40.002.

How many shares does Jane Prior beneficially own after the transactions?

Following the reported transactions, Prior beneficially owns 123,666 shares.

Were the sales executed under a trading plan for COCO insider?

Yes. The filing states the sales were effected pursuant to a Rule 10b5-1 trading plan.

What option holdings and vesting details are disclosed for the reporting person?

The Form discloses multiple non-qualified stock options with exercise prices from $10.178 up to $33.36, various exercise/expiration dates, and specified vesting schedules; several options are noted as fully vested and currently exercisable.

What was the sale price range for the shares sold?

The shares sold were transacted at prices ranging from $40.00 to $40.03, inclusive; the reported weighted average price is $40.002.